Teva Pharmaceutical Industries Ltd ADR buy UBS Group AG
Start price
11.07.24
/
50%
€15.70
Target price
11.07.25
€22.04
Performance (%)
-0.32%
Price
27.09.24
€15.65
Summary
This prediction is currently active. The BUY prediction by UBS_Group_AG for Teva Pharmaceutical Industries Ltd ADR is nearly unchanged. This prediction currently runs until 11.07.25. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Teva Pharmaceutical Industries Ltd ADR | -0.318% | -0.318% |
iShares Core DAX® | 3.523% | 3.763% |
iShares Nasdaq 100 | 1.026% | 2.380% |
iShares Nikkei 225® | -0.063% | 0.000% |
iShares S&P 500 | 0.557% | 2.222% |
Comments by UBS_Group_AG for this prediction
In the thread Teva Pharmaceutical Industries Ltd ADR diskutieren
Teva Pharmaceutical Industries Limited (NYSE: TEVA) had its price target raised by analysts at UBS Group AG from $22.00 to $24.00. They now have a "buy" rating on the stock.
Ratings data for TEVA provided by MarketBeat
Stopped prediction by UBS_Group_AG for Teva Pharmaceutical Industries Ltd ADR
Teva Pharmaceutical Industries Ltd ADR
Start price
Target price
Perf. (%)
€16.90
03.09.24
03.09.24
€23.55
03.09.25
03.09.25
-7.40%
27.09.24
27.09.24
Teva Pharmaceutical Industries Ltd ADR
Start price
Target price
Perf. (%)
€8.94
27.11.23
27.11.23
€11.87
27.11.24
27.11.24
75.06%
27.09.24
27.09.24